Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Morgan Stanley to hold a virtual conference » 08:08
09/16/20
09/16
08:08
09/16/20
08:08
ZTS

Zoetis

$162.21 /

+1.33 (+0.83%)

, GLPG

Galapagos

$135.37 /

+0.75 (+0.56%)

, DBVT

DBV Technologies

$1.97 /

-0.005 (-0.25%)

, CI

Cigna

$166.00 /

-6 (-3.49%)

, BDX

Becton Dickinson

$226.09 /

-9.99 (-4.23%)

, AVTR

Avantor

$21.76 /

-0.17 (-0.78%)

, ALC

Alcon

$57.07 /

+0.28 (+0.49%)

, TDOC

Teladoc

$194.91 /

+1.315 (+0.68%)

, INCY

Incyte

$91.48 /

-1.73 (-1.86%)

, DGX

Quest Diagnostics

$113.56 /

+0.74 (+0.66%)

, JNJ

Johnson & Johnson

$148.88 /

+0.485 (+0.33%)

, PAHC

Phibro Animal Health

$18.50 /

+0.34 (+1.87%)

, ABBV

AbbVie

$90.90 /

+0.43 (+0.48%)

, TNDM

TNDM

/

+

, ABC

AmerisourceBergen

$94.93 /

+0.34 (+0.36%)

, CRY

CryoLife

$16.70 /

+0.355 (+2.17%)

, CTLT

Catalent

$84.40 /

+0.5 (+0.60%)

, TXG

10x Genomics

$118.60 /

-2.35 (-1.94%)

, FULC

Fulcrum Therapeutics

$7.84 /

-0.31 (-3.80%)

, KRYS

Krystal Biotech

$46.20 /

-0.92 (-1.95%)

, MYL

Mylan

$15.93 /

+0.15 (+0.95%)

, LLY

Eli Lilly

$150.09 /

+1.09 (+0.73%)

, SUPN

Supernus

$21.95 /

+0.2 (+0.92%)

, SRRK

Scholar Rock

$16.96 /

+0.54 (+3.29%)

, BHC

Bausch Health

$16.26 /

+0.36 (+2.26%)

, HZNP

Horizon Therapeutics

$79.00 /

+2.36 (+3.08%)

, DRNA

Dicerna

$18.00 /

-0.29 (-1.59%)

, RYTM

Rhythm Pharmaceuticals

$30.19 /

-0.3 (-0.98%)

18th Annual Global…

18th Annual Global Healthcare Virtual Conference will be held on September 14-18 with webcasted presentations to begin on September 16 at 8 am. Webcast LinkWebcast Link

ShowHide Related Items >><<
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CRY CryoLife
$16.70 /

+0.355 (+2.17%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

08/18/20 Argus
Elanco price target raised to $30 from $26 at Argus
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
08/14/20 Edward Jones
Zoetis upgraded to Buy from Hold at Edward Jones
08/12/20
Fly Intel: Top five analyst downgrades
GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Jefferies
Galapagos downgraded to Hold from Buy at Jefferies
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
08/19/20 Piper Sandler
AbbVie commercial efforts easier after Gilead CRL, says Piper Sandler
DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

08/06/20 Societe Generale
DBV Technologies downgraded to Sell at Societe Generale after FDA CRL
08/06/20 Societe Generale
DBV Technologies downgraded to Sell from Buy at Societe Generale
08/05/20 Morgan Stanley
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley
08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
CI Cigna
$166.00 /

-6 (-3.49%)

09/11/20 Jefferies
Cigna performance 'seems neglected,' says Jefferies
09/01/20 Cleveland Research
Amazon partnership with Cigna would make sense for both, says Cleveland Research
08/06/20 RBC Capital
Ontrak price target raised to $50 from $35 at RBC Capital
07/01/20 SVB Leerink
Cigna reinstated with a Market Perform at SVB Leerink
BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
08/27/20 Wells Fargo
Abbott not focused on bringing Covid-19 test to home, says Wells Fargo
08/27/20 Morgan Stanley
Abbott 'may change the game' in COVID testing with BinaxNOW, says Morgan Stanley
08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
AVTR Avantor
$21.76 /

-0.17 (-0.78%)

09/14/20 Morgan Stanley
Avantor initiated with an Overweight at Morgan Stanley
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
08/03/20 Truist
Avantor price target raised to $29 from $21 at Truist
07/30/20 JPMorgan
Avantor price target raised to $25 from $18 at JPMorgan
ALC Alcon
$57.07 /

+0.28 (+0.49%)

09/01/20 Berenberg
Alcon price target lowered to CHF 62 from CHF 64 at Berenberg
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
08/27/20 Societe Generale
Alcon downgraded to Sell from Hold at Societe Generale
08/20/20 Stephens
Alcon's new product launches at or above expectations, says Stephens
TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Teladoc upgraded to Buy from Hold at Berenberg
INCY Incyte
$91.48 /

-1.73 (-1.86%)

09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

09/11/20 Baird
Quest Diagnostics sentiment and valuation missing big picture, says Baird
09/01/20 Deutsche Bank
Quest to see minimal financial impact from Florida news, says Deutsche Bank
08/28/20 Mizuho
Quest, LabCorp weakness yesterday should be bought, says Mizuho
07/29/20
Fly Intel: Top five analyst upgrades
JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/20/20 Morgan Stanley
AbbVie price target raised to $108 from $95 at Morgan Stanley
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

08/31/20 Argus
Argus sees 'solid' growth opportunities for AmerisourceBergen
08/10/20 Credit Suisse
AmerisourceBergen price target raised to $118 from $111 at Credit Suisse
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
CRY CryoLife
$16.70 /

+0.355 (+2.17%)

05/01/20 Lake Street
CryoLife price target raised to $27 from $22 at Lake Street
04/03/20 Lake Street
CryoLife price target lowered to $22 from $38 at Lake Street
04/02/20 Lake Street
CryoLife should emerge stronger in coming years, says Lake Street
04/02/20 Needham
CryoLife price target lowered to $29 from $38 at Needham
CTLT Catalent
$84.40 /

+0.5 (+0.60%)

09/04/20 Deutsche Bank
Catalent price target raised to $91 from $62 at Deutsche Bank
09/01/20 Baird
Catalent price target raised to $100 from $90 at Baird
09/01/20 RBC Capital
Catalent price target raised to $98 from $94 at RBC Capital
TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

09/15/20 JPMorgan
10x Genomics price target raised to $140 from $110 at JPMorgan
09/09/20 Morgan Stanley
10x Genomics initiated with an Overweight at Morgan Stanley
08/12/20 JPMorgan
10x Genomics price target raised to $110 from $95 at JPMorgan
07/10/20
Fly Intel: Top five analyst initiations
FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
08/12/20 H.C. Wainwright
Fulcrum Therapeutics price target lowered to $20 from $28 at H.C. Wainwright
KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

08/19/20 Chardan
Chardan sees valuation upside through 2022 for Krystal Biotech
03/12/20 SMBC Nikko
Krystal Biotech initiated with an Outperform at SMBC Nikko
03/10/20 H.C. Wainwright
Krystal Biotech price target raised to $68 from $59 at H.C. Wainwright
09/26/19 Guggenheim
Krystal Biotech has 'room to run' despite doubling year-to-date, says Guggenheim
MYL Mylan
$15.93 /

+0.15 (+0.95%)

08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
06/18/20 Raymond James
Raymond James says Mylan win over Biogen has 'no real apparent financial upside'
06/18/20 Wedbush
Patent ruling 'creates a significant issue' for Biogen, says Wedbush
LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
09/03/20 Morgan Stanley
Morgan Stanley upgrades Eli Lilly on diabetes, Alzheimer's opportunities
09/03/20 Morgan Stanley
Eli Lilly upgraded to Overweight from Equal Weight at Morgan Stanley
SUPN Supernus
$21.95 /

+0.2 (+0.92%)

06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
06/15/20 Jefferies
Supernus resumed with a Hold at Jefferies
04/30/20 Piper Sandler
Supernus price target raised to $25 from $17 at Piper Sandler
11/08/19 Berenberg
Supernus downgraded to Hold from Buy at Berenberg
SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

03/12/20
Fly Intel: Top five analyst initiations
03/11/20 Baird
Scholar Rock initiated with an Outperform at Baird
BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

08/24/20 JPMorgan
Bausch Health shares can double into separation, says JPMorgan
08/24/20 H.C. Wainwright
Bausch Health price target lowered to $50 from $64 at H.C. Wainwright
08/19/20 Piper Sandler
Bausch Health risk/reward profile remains attractive, says Piper Sandler
08/07/20 Barclays
Bausch Health price target raised to $28 from $25 at Barclays
HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

09/09/20 JPMorgan
Horizon Therapeutics initiated with an Overweight at JPMorgan
08/27/20
Fly Intel: Top five analyst initiations
08/27/20 Piper Sandler
Piper survey points to longer-term growth for Horizon's Krystexxa
08/27/20 Citi
Horizon Therapeutics initiated with a Buy at Citi
DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CRY CryoLife
$16.70 /

+0.355 (+2.17%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

  • 11
    Sep
  • 20
    Aug
  • 07
    Aug
  • 11
    Jun
  • 21
    May
  • 19
    May
  • 21
    May
  • 04
    Feb
  • 30
    Jan
  • 08
    Jan
  • 16
    Oct
  • 09
    Oct
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CI Cigna
$166.00 /

-6 (-3.49%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

On The Fly
Fly Intel: Pre-market Movers » 08:59
08/31/20
08/31
08:59
08/31/20
08:59
AIMT

Aimmune

$12.60 /

+0.65 (+5.44%)

, DBVT

DBV Technologies

$2.07 /

-0.04 (-1.90%)

, HUN

Huntsman

$22.09 /

+0.52 (+2.41%)

, VNTR

Venator Materials

$1.99 /

+0.16 (+8.77%)

, BWEN

Broadwind

$3.70 /

+0.025 (+0.68%)

, SFET

Safe-T

$1.28 /

+0.025 (+1.99%)

, RGS

Regis

$9.07 /

+0.55 (+6.46%)

, KRKR

36Kr Holdings

$3.58 /

+0.13 (+3.77%)

, LPCN

Lipocine

$1.63 /

-0.005 (-0.31%)

, WMT

Walmart

$140.29 /

+3.64 (+2.66%)

, NIO

NIO Inc.

$18.51 /

-1.37 (-6.89%)

, BIGC

BigCommerce

$130.28 /

-10.14 (-7.22%)

Check out this morning's…

ShowHide Related Items >><<
WMT Walmart
$140.29 /

+3.64 (+2.66%)

SFET Safe-T
$1.28 /

+0.025 (+1.99%)

RGS Regis
$9.07 /

+0.55 (+6.46%)

NIO NIO Inc.
$18.51 /

-1.37 (-6.89%)

LPCN Lipocine
$1.63 /

-0.005 (-0.31%)

KRKR 36Kr Holdings
$3.58 /

+0.13 (+3.77%)

HUN Huntsman
$22.09 /

+0.52 (+2.41%)

DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

BWEN Broadwind
$3.70 /

+0.025 (+0.68%)

BIGC BigCommerce
$130.28 /

-10.14 (-7.22%)

AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

08/25/20 Roth Capital
Roth Capital would 'strongly recommend buying' Aimmune shares following QoL data
07/31/20 Roth Capital
Aimmune update on U.S. launch in-line with expectations, says Roth Capital
07/31/20 Cantor Fitzgerald
Aimmune price target lowered to $24 from $32 at Cantor Fitzgerald
07/23/20 Stifel
Stifel lowers Aimmune target to $18 after surveying 50 allergists
DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

08/06/20 Societe Generale
DBV Technologies downgraded to Sell at Societe Generale after FDA CRL
08/06/20 Societe Generale
DBV Technologies downgraded to Sell from Buy at Societe Generale
08/05/20 Morgan Stanley
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley
08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
HUN Huntsman
$22.09 /

+0.52 (+2.41%)

08/31/20 Goldman Sachs
Huntsman price target raised to $25 from $21 at Goldman Sachs
08/31/20 Barclays
Huntsman price target raised to $18 from $16 at Barclays
06/19/20
Fly Intel: Top five analyst downgrades
06/19/20 Seaport Global
Seaport Global downgrades Huntsman to Neutral on slower than expected recovery
VNTR Venator Materials
$1.99 /

+0.16 (+8.77%)

04/21/20 BMO Capital
Venator Materials downgraded to Market Perform from Outperform at BMO Capital
04/08/20 Citi
Venator Materials price target lowered to $1.40 from $2.30 at Citi
03/30/20 Goldman Sachs
Venator Materials downgraded to Neutral from Buy at Goldman Sachs
03/23/20 Jefferies
Jefferies downgrades 10 'lower conviction' Chemicals stocks to Hold
BWEN Broadwind
$3.70 /

+0.025 (+0.68%)

07/22/20 H.C. Wainwright
Wind 'a big beneficiary' in NY renewable energy expansion, says H.C. Wainwright
07/07/20 Craig-Hallum
Broadwind initiated with a Buy at Craig-Hallum
06/16/20 H.C. Wainwright
Broadwind initiated with a Buy at H.C. Wainwright
SFET Safe-T
$1.28 /

+0.025 (+1.99%)

RGS Regis
$9.07 /

+0.55 (+6.46%)

06/19/20 Loop Capital
Regis price target lowered to $15 from $21 at Loop Capital
10/07/19 Jefferies
Regis price target raised to $26 from $24 at Jefferies
KRKR 36Kr Holdings
$3.58 /

+0.13 (+3.77%)

12/04/19 Needham
36Kr Holdings initiated with a Buy at Needham
LPCN Lipocine
$1.63 /

-0.005 (-0.31%)

05/27/20 H.C. Wainwright
Lipocine price target raised to $3 from $2 at H.C. Wainwright
11/11/19 H.C. Wainwright
Lipocine price target lowered to $2 from $5 at H.C. Wainwright
11/11/19 Ladenburg
Lipocine downgraded to Neutral from Buy at Ladenburg
WMT Walmart
$140.29 /

+3.64 (+2.66%)

08/31/20 R5 Capital
Walmart downgraded to Hold at R5 Capital on slowing sales, TikTok deal caution
08/31/20 R5 Capital
Walmart downgraded to Hold from Buy at R5 Capital
08/28/20 Jefferies
Joint deal for TikTok could be 'transformative move' for Walmart, says Jefferies
08/28/20 Morgan Stanley
Morgan Stanley 'open-minded' about Walmart's strategic rationale for TikTok deal
NIO NIO Inc.
$18.51 /

-1.37 (-6.89%)

08/28/20 Citi
NIO share issuance potentially earnings accretive, says Citi
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Morgan Stanley
Morgan Stanley upgrades NIO Inc. to Overweight after recent Hefei funding deal
08/26/20 Citi
NIO Inc. price target raised to $18.10 from $16 at Citi
BIGC BigCommerce
$130.28 /

-10.14 (-7.22%)

08/31/20 Raymond James
BigCommerce initiated at Market Perform on valuation at Raymond James
08/31/20 Truist
BigCommerce initiated with a Hold at Truist
08/31/20 Truist
BigCommerce initiated with a Hold at Truist
08/31/20 Morgan Stanley
BigCommerce initiated with an Underweight at Morgan Stanley
WMT Walmart
$140.29 /

+3.64 (+2.66%)

VNTR Venator Materials
$1.99 /

+0.16 (+8.77%)

SFET Safe-T
$1.28 /

+0.025 (+1.99%)

RGS Regis
$9.07 /

+0.55 (+6.46%)

NIO NIO Inc.
$18.51 /

-1.37 (-6.89%)

LPCN Lipocine
$1.63 /

-0.005 (-0.31%)

KRKR 36Kr Holdings
$3.58 /

+0.13 (+3.77%)

HUN Huntsman
$22.09 /

+0.52 (+2.41%)

DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

BWEN Broadwind
$3.70 /

+0.025 (+0.68%)

AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

  • 31
    Aug
  • 05
    Aug
  • 11
    Jun
  • 30
    Jan
  • 14
    Nov
  • 01
    Nov
  • 08
    Nov
  • 09
    Oct
WMT Walmart
$140.29 /

+3.64 (+2.66%)

NIO NIO Inc.
$18.51 /

-1.37 (-6.89%)

HUN Huntsman
$22.09 /

+0.52 (+2.41%)

BWEN Broadwind
$3.70 /

+0.025 (+0.68%)

WMT Walmart
$140.29 /

+3.64 (+2.66%)

VNTR Venator Materials
$1.99 /

+0.16 (+8.77%)

NIO NIO Inc.
$18.51 /

-1.37 (-6.89%)

DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

BIGC BigCommerce
$130.28 /

-10.14 (-7.22%)

AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

WMT Walmart
$140.29 /

+3.64 (+2.66%)

NIO NIO Inc.
$18.51 /

-1.37 (-6.89%)

LPCN Lipocine
$1.63 /

-0.005 (-0.31%)

HUN Huntsman
$22.09 /

+0.52 (+2.41%)

BIGC BigCommerce
$130.28 /

-10.14 (-7.22%)

Hot Stocks
DBV up 7% to $2.21 after Nestle acquires competitor Aimmune  05:32
08/31/20
08/31
05:32
08/31/20
05:32
DBVT

DBV Technologies

$2.07 /

-0.04 (-1.90%)

, AIMT

Aimmune

$12.60 /

+0.65 (+5.44%)

 
ShowHide Related Items >><<
DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

08/06/20 Societe Generale
DBV Technologies downgraded to Sell at Societe Generale after FDA CRL
08/06/20 Societe Generale
DBV Technologies downgraded to Sell from Buy at Societe Generale
08/05/20 Morgan Stanley
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley
08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

08/25/20 Roth Capital
Roth Capital would 'strongly recommend buying' Aimmune shares following QoL data
07/31/20 Roth Capital
Aimmune update on U.S. launch in-line with expectations, says Roth Capital
07/31/20 Cantor Fitzgerald
Aimmune price target lowered to $24 from $32 at Cantor Fitzgerald
07/23/20 Stifel
Stifel lowers Aimmune target to $18 after surveying 50 allergists
DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

  • 30
    Jan
  • 09
    Oct
DBVT DBV Technologies
$2.07 /

-0.04 (-1.90%)

AIMT Aimmune
$12.60 /

+0.65 (+5.44%)

Over a month ago
Downgrade
DBV Technologies downgraded to Sell at Societe Generale after FDA CRL » 06:09
08/06/20
08/06
06:09
08/06/20
06:09
DBVT

DBV Technologies

$2.48 /

+0.11 (+4.64%)

Societe Generale analyst…

Societe Generale analyst Delphine Le Louet downgraded DBV Technologies to Sell from Buy with a price target of EUR 2.90, down from EUR 28.50 after the FDA issued a complete response letter for the Viaskin pediatric peanut patch. The analyst says the CRL was a "surprise," as it was thought that the clinical data were strong enough for FDA approval and was unaware of the manufacturing issues that have arisen.

ShowHide Related Items >><<
DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

08/06/20 Societe Generale
DBV Technologies downgraded to Sell from Buy at Societe Generale
08/05/20 Morgan Stanley
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley
08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
08/05/20 Citi
DBV Technologies price target lowered to $4 from $10 at Citi
DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

  • 30
    Jan
  • 09
    Oct
DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

Downgrade
DBV Technologies downgraded to Sell from Buy at Societe Generale » 04:39
08/06/20
08/06
04:39
08/06/20
04:39
DBVT

DBV Technologies

$2.48 /

+0.11 (+4.64%)

Societe Generale analyst…

Societe Generale analyst double Delphine Le Louet downgraded DBV Technologies to Sell from Buy with a EUR 2.90 price target after the FDA issued a Complete Response Letter for Viaskin Peanut.

ShowHide Related Items >><<
DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

08/05/20 Morgan Stanley
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley
08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
08/05/20 Citi
DBV Technologies price target lowered to $4 from $10 at Citi
08/05/20 H.C. Wainwright
DBV Technologies price target lowered to $14 from $25 at H.C. Wainwright
DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

  • 30
    Jan
  • 09
    Oct
DBVT DBV Technologies
$2.48 /

+0.11 (+4.64%)

Recommendations
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley » 10:42
08/05/20
08/05
10:42
08/05/20
10:42
DBVT

DBV Technologies

$2.50 /

+0.13 (+5.49%)

Morgan Stanley analyst…

Morgan Stanley analyst Vikram Purohit lowered the firm's price target on DBV Technologies to $2 from $4 and keeps an Equal Weight rating on the shares after the company received a Complete Response Letter for Viaskin Peanut, with the FDA asking for patch modifications and additional clinical data. The analyst does not see validation for a revised patch until mid-2021 at the earliest. Purohit removed Viaskin Peanut from the base case and now values the company on cash.

ShowHide Related Items >><<
DBVT DBV Technologies
$2.50 /

+0.13 (+5.49%)

DBVT DBV Technologies
$2.50 /

+0.13 (+5.49%)

08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
08/05/20 Citi
DBV Technologies price target lowered to $4 from $10 at Citi
08/05/20 H.C. Wainwright
DBV Technologies price target lowered to $14 from $25 at H.C. Wainwright
08/04/20 Bryan Garnier
DBV Technologies downgraded to Sell from Neutral at Bryan Garnier
DBVT DBV Technologies
$2.50 /

+0.13 (+5.49%)

  • 30
    Jan
  • 09
    Oct
DBVT DBV Technologies
$2.50 /

+0.13 (+5.49%)

Recommendations
JMP halves DBV Technologies target but sees positive risk/reward » 08:57
08/05/20
08/05
08:57
08/05/20
08:57
DBVT

DBV Technologies

$2.37 /

-1.72 (-42.05%)

JMP Securities analyst…

JMP Securities analyst Jonathan Wolleben halved the firm's price target on DBV Technologies to $5 from $10 and keeps an Outperform rating on the shares. The Complete Response Letter from the FDA points to a longer path to potential approval for Viaskin Peanut, Wolleben tells investors in a research note. The analyst share management's view that the key question is what new clinical data FDA wants from the modified patch. He notes that clarity should come soon as DBV expects to meet with the FDA within 60 days. Wolleben now models a launch in 2024 with a 50% probability of success. With the shares trading near the company's cash of $2.31 per share, no need to raise capital in the near term and the ability to cut costs further, the analyst sees a positive risk/reward profile.

ShowHide Related Items >><<
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

08/05/20 Citi
DBV Technologies price target lowered to $4 from $10 at Citi
08/05/20 H.C. Wainwright
DBV Technologies price target lowered to $14 from $25 at H.C. Wainwright
08/04/20 Bryan Garnier
DBV Technologies downgraded to Sell from Neutral at Bryan Garnier
07/13/20 Cowen
Cowen starts Aimmune at Outperform, sees 'significant ramp' post COVID
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

  • 30
    Jan
  • 09
    Oct
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

Recommendations
DBV Technologies price target lowered to $4 from $10 at Citi » 06:32
08/05/20
08/05
06:32
08/05/20
06:32
DBVT

DBV Technologies

$2.37 /

-1.72 (-42.05%)

Citi analyst Joel Beatty…

Citi analyst Joel Beatty lowered the firm's price target on DBV Technologies to $4 from $10 and keeps a Buy rating on the shares. The Complete Response Letter given by the FDA to DBV's peanut allergy patch is a "very meaningful negative," Beatty tells investors in a research note. The analyst assumes a new Phase 3 trial to demonstrate efficacy will be needed and his base case delays the projected launch year to 2023. However, the patch is very likely effective, says Beatty.

ShowHide Related Items >><<
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

08/05/20 H.C. Wainwright
DBV Technologies price target lowered to $14 from $25 at H.C. Wainwright
08/04/20 Bryan Garnier
DBV Technologies downgraded to Sell from Neutral at Bryan Garnier
07/13/20 Cowen
Cowen starts Aimmune at Outperform, sees 'significant ramp' post COVID
07/02/20 JMP Securities
JMP Securities positive on DBV Technologies' risk-reward
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

  • 30
    Jan
  • 09
    Oct
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

Recommendations
DBV Technologies price target lowered to $14 from $25 at H.C. Wainwright » 06:11
08/05/20
08/05
06:11
08/05/20
06:11
DBVT

DBV Technologies

$2.37 /

-1.72 (-42.05%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Andrew Fein lowered the firm's price target on DBV Technologies to $14 from $25 and keeps a Buy rating on the shares after the FDA issued a Complete Response Letter regarding review of the company's application for its Viaskin Peanut patch in the immunotherapy treatment of peanut allergic children ages 4-11 years old. The "timing delay offers chance to clear lingering skeletons from the closet," Fein tells investors in a research note. No safety concerns were cited, says the analyst, who expects the next update informed from FDA feedback to occur approximately in October or November. New clarity on trial design can help to remove the overhang that has existed since the confidence interval issue, Fein contends.

ShowHide Related Items >><<
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

08/04/20 Bryan Garnier
DBV Technologies downgraded to Sell from Neutral at Bryan Garnier
07/13/20 Cowen
Cowen starts Aimmune at Outperform, sees 'significant ramp' post COVID
07/02/20 JMP Securities
JMP Securities positive on DBV Technologies' risk-reward
06/29/20 Citi
DBV approval likely to be delayed beyond action date, says Citi
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

  • 30
    Jan
  • 09
    Oct
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 17:22
08/04/20
08/04
17:22
08/04/20
17:22
DIS

Disney

$117.45 /

+1.07 (+0.92%)

, WYNN

Wynn Resorts

$72.79 /

-0.24 (-0.33%)

, ATVI

Activision Blizzard

$86.34 /

+1.575 (+1.86%)

, FOXA

Fox Corp.

$26.69 /

+0.33 (+1.25%)

, FOX

Fox Corp.

$26.68 /

+0.405 (+1.54%)

, F

Ford

$6.85 /

+0.16 (+2.39%)

, MSFT

Microsoft

$213.32 /

-3.28 (-1.51%)

, AAPL

Apple

$438.80 /

+3.14 (+0.72%)

, KODK

Eastman Kodak

$14.40 /

-0.4 (-2.70%)

, BLNK

Blink Charging

$11.35 /

+0.82 (+7.79%)

, CWK

Cushman & Wakefield

$10.45 /

+0.22 (+2.15%)

, HLIT

Harmonic

$7.02 /

+1.4 (+24.91%)

, SEDG

SolarEdge

$195.52 /

+22 (+12.68%)

, DBVT

DBV Technologies

$2.37 /

-1.72 (-42.05%)

, SPCE

Virgin Galactic

$20.72 /

-3.31 (-13.78%)

, RL

Ralph Lauren

$66.65 /

-2.94 (-4.22%)

Stocks closed the session…

ShowHide Related Items >><<
WYNN Wynn Resorts
$72.79 /

-0.24 (-0.33%)

SPCE Virgin Galactic
$20.72 /

-3.31 (-13.78%)

SEDG SolarEdge
$195.52 /

+22 (+12.68%)

RL Ralph Lauren
$66.65 /

-2.94 (-4.22%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

KODK Eastman Kodak
$14.40 /

-0.4 (-2.70%)

HLIT Harmonic
$7.02 /

+1.4 (+24.91%)

FOXA Fox Corp.
$26.69 /

+0.33 (+1.25%)

FOX Fox Corp.
$26.68 /

+0.405 (+1.54%)

F Ford
$6.85 /

+0.16 (+2.39%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

CWK Cushman & Wakefield
$10.45 /

+0.22 (+2.15%)

BLNK Blink Charging
$11.35 /

+0.82 (+7.79%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
08/05/20 Guggenheim
Disney upgraded to Buy from Neutral at Guggenheim
WYNN Wynn Resorts
$72.79 /

-0.24 (-0.33%)

08/05/20 Deutsche Bank
Wynn Resorts price target lowered to $89 from $94 at Deutsche Bank
07/14/20 Union Gaming
Union Gaming upgrades Wynn Resorts to Buy on Macau reopening
07/14/20 Union Gaming
Wynn Resorts upgraded to Buy from Hold at Union Gaming
06/11/20 JPMorgan
Wynn Resorts' Macau SAR results better than feared, says JPMorgan
ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

08/05/20 Barclays
Activision Blizzard price target raised to $98 from $90 at Barclays
08/05/20 Morgan Stanley
Activision Blizzard price target raised to $100 from $88 at Morgan Stanley
08/05/20 UBS
Activision Blizzard price target raised to $106 from $84 at UBS
08/05/20 Oppenheimer
Activision Blizzard price target raised to $95 from $75 at Oppenheimer
FOXA Fox Corp.
$26.69 /

+0.33 (+1.25%)

07/24/20 Loop Capital
Fox Corp. upgraded to Buy from Hold at Loop Capital
07/24/20 Loop Capital
Fox Corp. upgraded to Buy from Hold at Loop Capital
07/15/20 Guggenheim
Fox Corp. price target lowered to $29 from $32 at Guggenheim
07/13/20
Fly Intel: Top five analyst initiations
FOX Fox Corp.
$26.68 /

+0.405 (+1.54%)

05/28/20 Jefferies
Flutter Entertainment share sale a 'confident, proactive step,' says Jefferies
04/13/20 Citi
Fox Corp. resumed with a Neutral at Citi
04/06/20 Wells Fargo
Fox Corp. price target lowered to $20 from $33 at Wells Fargo
F Ford
$6.85 /

+0.16 (+2.39%)

08/04/20 Jefferies
Ford, FCA price targets raised at Jefferies following earnings
07/24/20 Barclays
Ford price target raised to $7 from $4 at Barclays
07/15/20 Jefferies
Jefferies says Fox Factory absence on Bronco doesn't impair competitive position
07/14/20 Baird
Fox Factory down on Ford picking Bilstein for Bronco shocks, says Baird
MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
AAPL Apple
$438.80 /

+3.14 (+0.72%)

08/05/20 Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
08/05/20 Bernstein
2021 could be 'big year' for Apple iPhones, says Bernstein
08/05/20 BofA
BofA downgrades Apple to Neutral, ups price target to $470
08/05/20 BofA
Apple downgraded to Neutral from Buy at BofA
KODK Eastman Kodak
$14.40 /

-0.4 (-2.70%)

BLNK Blink Charging
$11.35 /

+0.82 (+7.79%)

08/26/19 ThinkEquity
Blink Charging initiated with a Buy at ThinkEquity
CWK Cushman & Wakefield
$10.45 /

+0.22 (+2.15%)

04/09/20 JPMorgan
Cushman & Wakefield downgraded to Neutral as 'riskiest' CRE broker at JPMorgan
04/09/20 JPMorgan
Cushman & Wakefield downgraded to Neutral from Overweight at JPMorgan
10/18/19 BofA
Cushman & Wakefield reinstated with a Neutral at BofA/Merrill
HLIT Harmonic
$7.02 /

+1.4 (+24.91%)

06/01/20 JPMorgan
Harmonic downgraded to Neutral on spending pushouts at JPMorgan
06/01/20 JPMorgan
Harmonic downgraded to Neutral from Overweight at JPMorgan
05/22/20
Fly Intel: Top five analyst initiations
05/22/20 Barclays
Harmonic initiated with an Equal Weight at Barclays
SEDG SolarEdge
$195.52 /

+22 (+12.68%)

08/04/20 JPMorgan
SolarEdge price target raised to $222 from $196 at JPMorgan
08/04/20 GLJ Research
SolarEdge explanations for inventory 'highly inconsistent,' says GLJ Research
08/04/20 Oppenheimer
SolarEdge price target raised to $207 from $151
08/03/20 JMP Securities
SolarEdge downgraded to Market Perform from Outperform at JMP Securities
DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
08/05/20 Citi
DBV Technologies price target lowered to $4 from $10 at Citi
08/05/20 H.C. Wainwright
DBV Technologies price target lowered to $14 from $25 at H.C. Wainwright
08/04/20 Bryan Garnier
DBV Technologies downgraded to Sell from Neutral at Bryan Garnier
SPCE Virgin Galactic
$20.72 /

-3.31 (-13.78%)

07/13/20 Alembic Global
Virgin Galactic initiated with an Overweight at Alembic Global
03/24/20 Morgan Stanley
Morgan Stanley upgrades Virgin Galactic to Overweight after over 70% drop
03/24/20 Morgan Stanley
Virgin Galactic upgraded to Overweight from Equal Weight at Morgan Stanley
03/03/20 Morgan Stanley
Lead up to next lunar landings can have 'powerful impact,' says Morgan Stanley
RL Ralph Lauren
$66.65 /

-2.94 (-4.22%)

08/05/20 Deutsche Bank
Ralph Lauren price target lowered to $75 from $80 at Deutsche Bank
07/20/20 Wells Fargo
Ralph Lauren price target lowered to $90 from $100 at Wells Fargo
06/22/20 RBC Capital
Ralph Lauren price target raised to $82 from $77 at RBC Capital
05/28/20 Needham
Ralph Lauren price target raised to $90 from $80 at Needham
WYNN Wynn Resorts
$72.79 /

-0.24 (-0.33%)

SPCE Virgin Galactic
$20.72 /

-3.31 (-13.78%)

SEDG SolarEdge
$195.52 /

+22 (+12.68%)

RL Ralph Lauren
$66.65 /

-2.94 (-4.22%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

HLIT Harmonic
$7.02 /

+1.4 (+24.91%)

FOXA Fox Corp.
$26.69 /

+0.33 (+1.25%)

FOX Fox Corp.
$26.68 /

+0.405 (+1.54%)

F Ford
$6.85 /

+0.16 (+2.39%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

CWK Cushman & Wakefield
$10.45 /

+0.22 (+2.15%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

  • 06
    Aug
  • 03
    Jun
  • 20
    May
  • 30
    Jan
  • 12
    Nov
  • 09
    Oct
WYNN Wynn Resorts
$72.79 /

-0.24 (-0.33%)

SPCE Virgin Galactic
$20.72 /

-3.31 (-13.78%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

KODK Eastman Kodak
$14.40 /

-0.4 (-2.70%)

FOXA Fox Corp.
$26.69 /

+0.33 (+1.25%)

FOX Fox Corp.
$26.68 /

+0.405 (+1.54%)

F Ford
$6.85 /

+0.16 (+2.39%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

WYNN Wynn Resorts
$72.79 /

-0.24 (-0.33%)

SPCE Virgin Galactic
$20.72 /

-3.31 (-13.78%)

SEDG SolarEdge
$195.52 /

+22 (+12.68%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

KODK Eastman Kodak
$14.40 /

-0.4 (-2.70%)

HLIT Harmonic
$7.02 /

+1.4 (+24.91%)

FOXA Fox Corp.
$26.69 /

+0.33 (+1.25%)

FOX Fox Corp.
$26.68 /

+0.405 (+1.54%)

F Ford
$6.85 /

+0.16 (+2.39%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

DBVT DBV Technologies
$2.37 /

-1.72 (-42.05%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

WYNN Wynn Resorts
$72.79 /

-0.24 (-0.33%)

SPCE Virgin Galactic
$20.72 /

-3.31 (-13.78%)

SEDG SolarEdge
$195.52 /

+22 (+12.68%)

RL Ralph Lauren
$66.65 /

-2.94 (-4.22%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

KODK Eastman Kodak
$14.40 /

-0.4 (-2.70%)

FOXA Fox Corp.
$26.69 /

+0.33 (+1.25%)

F Ford
$6.85 /

+0.16 (+2.39%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

BLNK Blink Charging
$11.35 /

+0.82 (+7.79%)

ATVI Activision Blizzard
$86.34 /

+1.575 (+1.86%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

MSFT Microsoft
$213.32 /

-3.28 (-1.51%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.